Some CAR-T cells harboring both CD28 and 4-1BB domains display rapid effector functions via glycolysis, but they also retain oxidative functions that support memory formation and long-term persistence (51, 52), suggesting that the combination of multiple metabolic pathways is suitable for T cells to exert anti-tumor effects. The gene discussed is CD28; the disease is neoplasm.